Primary |
Sinusitis |
15.6% |
Asthma |
13.3% |
Hypersensitivity |
13.3% |
Rhinitis |
11.1% |
Bronchial Hyperreactivity |
4.4% |
Hypertension |
4.4% |
Multiple Allergies |
4.4% |
Nasal Congestion |
4.4% |
Osteoporosis |
4.4% |
Rhinitis Allergic |
4.4% |
Rhinorrhoea |
4.4% |
Ear Disorder |
2.2% |
Ear Pain |
2.2% |
Eustachian Tube Dysfunction |
2.2% |
Nasal Inflammation |
2.2% |
Postnasal Drip |
2.2% |
Seasonal Allergy |
2.2% |
Swelling |
2.2% |
|
Cataract |
12.1% |
Paraesthesia |
9.1% |
Visual Acuity Reduced |
9.1% |
Epistaxis |
6.1% |
Hypersensitivity |
6.1% |
Palpitations |
6.1% |
Product Quality Issue |
6.1% |
Retinal Tear |
6.1% |
Weight Decreased |
6.1% |
Anosmia |
3.0% |
Drug Ineffective |
3.0% |
Dyspnoea |
3.0% |
Hepatomegaly |
3.0% |
Hydronephrosis |
3.0% |
Hypoaesthesia |
3.0% |
Hyposmia |
3.0% |
Loss Of Consciousness |
3.0% |
Macular Degeneration |
3.0% |
Muscle Twitching |
3.0% |
Nasal Septum Perforation |
3.0% |
|
Secondary |
Arthritis |
11.1% |
Depression |
11.1% |
Metastases To Bone |
11.1% |
Sinusitis |
9.3% |
Bronchial Hyperreactivity |
7.4% |
Rhinitis |
7.4% |
Asthma |
5.6% |
Hypersensitivity |
5.6% |
Product Used For Unknown Indication |
5.6% |
Bronchitis |
3.7% |
Rhinitis Allergic |
3.7% |
Seasonal Allergy |
3.7% |
Atrial Fibrillation |
1.9% |
Chronic Obstructive Pulmonary Disease |
1.9% |
Eustachian Tube Dysfunction |
1.9% |
Infection |
1.9% |
Multiple Allergies |
1.9% |
Osteoporosis |
1.9% |
Postnasal Drip |
1.9% |
Rhinorrhoea |
1.9% |
|
Paraesthesia |
11.5% |
Visual Acuity Reduced |
11.5% |
Pyrexia |
7.7% |
Weight Decreased |
7.7% |
Arthralgia |
3.8% |
Cervicobrachial Syndrome |
3.8% |
Dental Caries |
3.8% |
Headache |
3.8% |
International Normalised Ratio Increased |
3.8% |
Lip Ulceration |
3.8% |
Loss Of Consciousness |
3.8% |
Obesity |
3.8% |
Pharyngitis |
3.8% |
Retinal Tear |
3.8% |
Rhinitis |
3.8% |
Rotator Cuff Syndrome |
3.8% |
Sinusitis |
3.8% |
Upper Respiratory Tract Infection |
3.8% |
Upper-airway Cough Syndrome |
3.8% |
Vertigo |
3.8% |
|
Concomitant |
Drug Use For Unknown Indication |
21.6% |
Product Used For Unknown Indication |
14.1% |
Asthma |
9.1% |
Prophylaxis |
5.3% |
Pain |
4.8% |
Breast Cancer Metastatic |
4.6% |
Hypersensitivity |
4.6% |
Gastrooesophageal Reflux Disease |
4.2% |
Hypertension |
3.9% |
Breast Cancer |
3.6% |
Depression |
3.1% |
Rhinitis Allergic |
2.8% |
Migraine |
2.7% |
Ill-defined Disorder |
2.5% |
Neoplasm Malignant |
2.5% |
Ovarian Cancer |
2.5% |
Blood Cholesterol Increased |
2.3% |
Sinusitis |
2.2% |
Contraception |
1.9% |
Insomnia |
1.7% |
|
Weight Increased |
13.0% |
Weight Decreased |
10.3% |
Wound Treatment |
9.2% |
Vomiting |
8.6% |
Pruritus |
5.4% |
Wheezing |
4.9% |
Pain In Extremity |
4.3% |
Pulmonary Embolism |
4.3% |
Drug Ineffective |
3.8% |
Vertigo |
3.8% |
Wound Infection |
3.8% |
Hypersensitivity |
3.2% |
Myocardial Infarction |
3.2% |
Nausea |
3.2% |
Pain |
3.2% |
Pharmaceutical Product Complaint |
3.2% |
Product Quality Issue |
3.2% |
Sleep Disorder |
3.2% |
Type 2 Diabetes Mellitus |
3.2% |
Arthralgia |
2.7% |
|
Interacting |
Asthma |
50.0% |
Rhinitis |
50.0% |
|
Drug Ineffective |
72.7% |
Throat Tightness |
27.3% |
|